Sangamo Biosciences reported $0 in Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acceleron Pharma XLRN:US $ 0M 0M
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Amgen AMGN:US $ 37579M 4797M
Avrobio Inc AVRO:US $ 0 0
Bayer BAYN:GR € 41766M 1394M
Biocryst Pharmaceuticals BCRX:US $ 304.16M 10.51M
Biogen BIIB:US $ 7271.1M 1.9M
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
GlaxoSmithKline GSK:LN 25605M 122M
Intercept Pharmaceuticals ICPT:US $ 530.4M 45.42M
IONIS PHARMACEUT IONS:US $ 1303M 7.54M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Novartis NOVN:VX SF 34243M 1526M
Omeros OMER:US $ 313.02M 433K
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1094.91M 1.93M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 513.26M 11.67M